| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |